JDP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.308150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.638800E-01
Normal-vs-Stage2
1.138420E-01
Normal-vs-Stage3
1.717190E-01
Normal-vs-Stage4
6.730800E-01
Stage1-vs-Stage2
6.004800E-01
Stage1-vs-Stage3
3.914400E-01
Stage1-vs-Stage4
6.801600E-01
Stage2-vs-Stage3
4.000800E-01
Stage2-vs-Stage4
2.923200E-01
Stage3-vs-Stage4
1.764980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.376040E-01
Normal-vs-AfricanAmerican
2.450000E-01
Normal-vs-Asian
1.850070E-02
Caucasian-vs-AfricanAmerican
6.410800E-01
Caucasian-vs-Asian
5.798200E-03
AfricanAmerican-vs-Asian
1.828040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.564620E-01
Normal-vs-Female
1.012770E-01
Male-vs-Female
7.426200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.328600E-01
Normal-vs-Age(41-60Yrs)
2.695600E-01
Normal-vs-Age(61-80Yrs)
6.535900E-02
Normal-vs-Age(81-100Yrs)
1.967800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.342400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.352000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.003780E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.326400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.308200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.968400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.032100E-02
Normal-vs-Daily Drinker
2.654600E-01
Normal-vs-Weekly Drinker
2.610200E-01
Normal-vs-Occasional Drinker
1.183570E-01
Normal-vs-Social Drinker
2.266800E-01
Non Drinker-vs-Daily Drinker
2.723000E-01
Non Drinker-vs-Weekly Drinker
2.387200E-01
Non Drinker-vs-Occasional Drinker
7.501400E-01
Non Drinker-vs-Social Drinker
1.419810E-01
Daily Drinker-vs-Weekly Drinker
8.760800E-01
Daily Drinker-vs-Occasional Drinker
4.779000E-01
Daily Drinker-vs-Social Drinker
7.196600E-01
Weekly Drinker-vs-Occasional Drinker
3.917000E-01
Weekly Drinker-vs-Social Drinker
8.424000E-01
Occasional Drinker-vs-Social Drinker
2.529600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.750400E-01
Normal-vs-Grade 2
7.486800E-01
Normal-vs-Grade 3
7.902200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.410100E-02
Grade 1-vs-Grade 3
1.352380E-01
Grade 1-vs-Grade 4
7.750400E-01
Grade 2-vs-Grade 3
4.220200E-01
Grade 2-vs-Grade 4
7.486800E-01
Grade 3-vs-Grade 4
7.902200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.368760E-01
Normal-vs-NonDiabetic
1.244560E-01
Diabetic-vs-NonDiabetic
7.917200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.206600E-01
Normal-vs-NoPancreatitis
1.413610E-01
Pancreatitis-vs-NoPancreatitis
9.900200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.526500E-02
Normal-vs-N1
1.702160E-01
N0-vs-N1
1.269420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.321500E-02
Normal-vs-TP53-NonMutant
1.932960E-01
TP53-Mutant-vs-TP53-NonMutant
6.533400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
